Employers are experiencing alarming increases in drug spend.
Most payers only manage drug discounts and rebates.
Meaningful savings result from a focus on value and appropriate use.
Take back control of your benefit.
Archimedes is helping plan sponsors address the rising cost of specialty medications through our unique specialty drug PBM solution.
Specialty medications coming through the medical benefit represent 40% of specialty spend, yet are often minimally managed with little to no visibility for employers.
Archimedes’ MEDiQ addresses the inherent limitations with managing these high cost drugs to deliver significant savings for clients.
PBMs should make 100% of their revenue from fees paid directly by their clients. This alignment of financial interests between the PBM and client is essential to managing costs.
Coverage should be based on lowest net cost and value, not on rebate maximization or optimizing the profits of the PBM-owned pharmacy.
Full visibility of performance metrics is a critical foundation to holding the PBM accountable.
Implementing this program was one of the best decisions our team has made. The savings are exceeding projections and our members are extremely happy.